Susan Blum

Susan Blum serves as Chief Financial Officer at CorMedix Therapeutics since August 2025, where responsibilities include strategic partnership with the CEO and executive leadership, financial stewardship, and capital allocation. Concurrently, Blum holds the position of Audit Committee Chair at BiomX, overseeing corporate governance for a clinical-stage biotech firm. Previous experience includes serving as CFO and VP of Finance at Melinta Therapeutics, where Blum played a pivotal role in strategic decision-making and financial restructuring. Additional roles encompassed experiences at Oracle Textura, Orbitz Worldwide, Facet Biotech, and EY, where expertise in financial reporting, compliance, and auditing was developed. Blum earned a BS in Business Commerce with a focus on Accounting from Santa Clara University Leavey School of Business.